The STOP-HPV Scale Up Study

Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Feb 14, 2025

Keywords

ClinConnect Summary

The STOP-HPV Scale Up Study is a clinical trial designed to improve the rates of vaccination against human papillomavirus (HPV), which is responsible for thousands of cancer cases in the U.S. each year. Despite having an effective vaccine, many adolescents are not receiving it. This study will test two different approaches to help doctors communicate better with parents about the HPV vaccine and ensure that children receive it during their routine healthcare visits. We will compare these new strategies to standard care to see which is more effective at encouraging families to start the HPV vaccination process.

To be part of this study, you need to be a patient at one of the participating healthcare practices and have a well-child care visit scheduled during the one-year period of the trial. You should be aged 9 to 12 years old and have never received an HPV vaccine before. If you join the trial, you will receive care from trained healthcare providers who will follow the new communication methods. This study aims to make it easier for parents and children to understand the importance of the HPV vaccine, ultimately helping to reduce cancer cases linked to this virus.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient of participating practice
• • Well child care visit during the 12-month intervention period
• • No prior dose of HPV vaccine at the time of the well child care visit
• • Age-eligible
• Exclusion Criteria:
• • Prior dose of HPV vaccine